filmov
tv
Private Equity & Antitrust – A New Approach? (Antitrust Matters #9)
Показать описание
In this episode, Jeffrey Shinder and Wyatt Fore are joined by Amanda Hamilton, Senior Correspondent at the Capitol Forum, to discuss emerging issues on private equity and antitrust. The three consider the extent to which enforcers have signaled a shift in approach by reviving dormant legal theories, including the prohibition of interlocking directorates.
10 Minutes of Antitrust: Private Equity in the Spotlight of US Antitrust Authorities
Private equity facing an antitrust showdown? | FT Due Diligence
How Private Equity Consumed America
Private Equity Spotlight: Preparing for 2025’s antitrust landscape
How private equity firms can resemble the empires they once broke up | FT Big Deal
What Are Blank Check Companies? How Antitrust Laws Affect SPACs
Why Private Equity SUCKS for (almost) Everyone
Antitrust in Healthcare - The Good, the Bad, and the Ugly
Plunder: Private Equity's Plan to Pillage America
Justice Department Investigates Blackstone, Apollo, KKR
U.S. antitrust developments: Antitrust enforcers take aim at private equity (Part 1)
Private Equity & Antitrust – A New Approach? (Antitrust Matters #9)
Sachin Khajuria and Brendan Ballou – Private Equity: Profit or Plunder? (EP.331)
10 Minutes of Antitrust: Tech Legislation, Litigation, and Risk Mitigation
ANTITRUST DIVISION SLAPS PRIVATE EQUITY GIANTS
The FTC is FINALLY Clamping Down on Healthcare Monopolies
#236 What Is PE Anyway? All the Questions You Were Afraid To Ask About Private Equity
The State of Antitrust & Private Equity in Health Care w/ Brent Fulton
FTC Chair Lina Khan SUES Private-Equity Backed Anesthesia Firm
David Rubenstein Sees M&A, Private Equity Picking Up in 2024
We Found Corporate America’s Biggest Enemy
This was the moment I learned more about private equity (the hard way). #shorts #grantcardone
Private Equity Under the Antitrust Microscope
Sidecar: FTC Suspends HSR Early Termination – How Will It Impact Deal Timing?
Комментарии